Gary Palmer

Dr. Palmer is an experienced medical oncologist who has led the way in the development and use of genomic medicine. He most recently was the Chief Medical Officer at Tempus, Inc., a leader in the field of genomics and real-world evidence. He has been in the biotech industry for twenty years and has held leadership roles at Amgen, Genomic Health, Foundation Medicine, and NantHealth. He has been instrumental in the development of Neulasta, the Oncotype DX Breast Assay, the Foundation One solid tumor multigene assay, and the Tempus XT and xF platforms.